Aachen papers per year
Papers 22
-
BOREAS: A Global, Phase III Study of the MDM2 Inhibitor Navtemadlin (KRT-232) in Relapsed/Refractory Myelofibrosis2022 Future Oncology article Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access cited by 1 patent
Srđan Verstovšek, Haifa Kathrin Al‐Ali, John O Mascarenhas, Andrew Charles Perkins, Alessandro Maria Vannucchi, Sanjay Ram Mohan, +8 more
40citations -
Imetelstat in intermediate-2 or high-risk myelofibrosis refractory to JAK inhibitor: IMpactMF phase III study design2022 Future Oncology article Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access cited by 1 patent
John O Mascarenhas, Claire N. Harrison, Jean‐Jacques Kiladjian, Rami S. Komrokji, Steffen Koschmieder, Alessandro Maria Vannucchi, +11 more
31citations -
MANEUVER: A Phase III study of pimicotinib to assess efficacy and safety in tenosynovial giant cell tumor patients2024 Future Oncology article Medicine Musculoskeletal synovial abnormalities and treatments Open access
Xiaohui Niu, Vinod Ravi, Boyao Shan, Qiuxiang Guo, Hao-Song Shi, Qingping Zou, +1 more
19citations -
The MOTION Study: A Randomized, Phase III Study of Vimseltinib for the Treatment of Tenosynovial Giant Cell Tumor2023 Future Oncology article Medicine Musculoskeletal synovial abnormalities and treatments Open access
William D. Tap, Maitreyi G. Sharma, Marc Vallee, Bryan D. Smith, Matthew Leigh Sherman, Rodrigo Ruiz‐Soto, +4 more
13citations -
Health-Related Quality of Life and Utility Outcomes with Selinexor in Relapsed/refractory Diffuse Large B-Cell Lymphoma2021 Future Oncology article Economics, Econometrics and Finance Health Systems, Economic Evaluations, Quality of Life Open access
Jatin J. Shah, Sharon Shacham, Michael G. Kauffman, Patrick Daniele, D. Tomaras, Gabriel Tremblay, +30 more
12citations -
The economic and humanistic burden of tenosynovial giant cell tumor: a targeted literature review2025 Future Oncology article Medicine Musculoskeletal synovial abnormalities and treatments Open access
Michiel A. J. van de Sande, Jean‐Yves Blay, William D. Tap, Max Lee, Emily Kaiser, Steph Beaver, +3 more
3citations -
Plain Language Summary of the MAIA Study of Daratumumab Plus Lenalidomide and Dexamethasone for the Treatment of People with Newly Diagnosed Multiple Myeloma
Thierry T.F. Facon, Shaji Kunnathu Kumar, Torben Plesner, Robert Zygmunt Orlowski, Philippe Moreau, Nizar Jacques Bahlis, +18 more
2citations -
An early economic evaluation of active surveillance for low-risk ductal carcinoma in situ2024 Future Oncology article Economics, Econometrics and Finance Health Systems, Economic Evaluations, Quality of Life Open access
Danalyn Byng, Michael Schaapveld, Esther H. Lips, Frederieke H van Duijnhoven, Jelle Wesseling, Wim H. van Harten, +1 more
1citations -
Interstitial lung disease epidemiology and etiology in patients with solid malignant tumors: a systematic literature review2025 Future Oncology review Medicine Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Open access
Egbert Frederik Smit, Simon M. Collin, Manoj Prahladan, Flavia Lujan, Emma Drane, Emily Kaiser, +2 more
0citations -
A plain language summary of the updated results from the PHAROS study: the combination of encorafenib plus binimetinib for people with BRAF V600E-mutant metastatic non-small cell lung cancer
Melissa L. Johnson, Egbert Frederik Smit, Enriqueta Felip, Suresh S. Ramalingam, Myung‐Ju Ahn, Anne S. Tsao, +15 more
0citations
Most active Aachen authors
-
Michiel A. J. van de Sande 11,956 citations overall6 papers
-
Hans A. J. Gelderblom 55,175 citations overall5 papers
-
Egbert Frederik Smit 62,735 citations overall4 papers
-
Steffen Koschmieder 11,677 citations overall2 papers
-
Veroniek M. van Praag 865 citations overall2 papers
-
Robert J. P. van der Wal 782 citations overall2 papers
-
Ibtissam Acem 236 citations overall2 papers
-
Jelle Wesseling 21,738 citations overall1 paper
-
Cornelis Kees Verhoef 20,961 citations overall1 paper
-
Dirk Jan Grünhagen 10,993 citations overall1 paper
-
JESSICA T. VERMEULEN 10,466 citations overall1 paper
-
Jens Panse 10,288 citations overall1 paper
-
Marie‐Luise Berres 7,504 citations overall1 paper
-
Emilie M.J. van Brummelen 4,842 citations overall1 paper
-
Joost S.P. Vermaat 3,482 citations overall1 paper